购物车
全部删除
您的购物车当前为空
Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and effectively induces cell death.


为众多的药物研发团队赋能,
让新药发现更简单!
Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and effectively induces cell death.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 1,950 | 5日内发货 | |
| 5 mg | ¥ 2,890 | 5日内发货 | |
| 25 mg | ¥ 10,500 | 6-8周 | |
| 50 mg | ¥ 13,700 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,180 | 5日内发货 |
| 产品描述 | Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and effectively induces cell death. |
| 靶点活性 | CDC7 (1 mM ATP):0.6 nM |
| 分子量 | 409.82 |
| 分子式 | C21H16ClN3O4 |
| CAS No. | 1402055-25-7 |
| 密度 | 1.517 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 5.2 mg/mL (12.69 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多